The estimated Net Worth of Steven L Fasman is at least $13.7 Million dollars as of 23 August 2023. Mr. Fasman owns over 817 units of Catalent stock worth over $4,400,038 and over the last 17 years he sold CTLT stock worth over $7,632,040. In addition, he makes $1,688,530 as Senior Vice President und General Counsel and Corporate Secretary at Catalent.
Steven has made over 16 trades of the Catalent stock since 2009, according to the Form 4 filled with the SEC. Most recently he sold 817 units of CTLT stock worth $36,479 on 23 August 2023.
The largest trade he's ever made was selling 34,714 units of Catalent stock on 4 October 2021 worth over $4,479,842. On average, Steven trades about 3,442 units every 119 days since 2008. As of 23 August 2023 he still owns at least 73,789 units of Catalent stock.
You can see the complete history of Mr. Fasman stock trades at the bottom of the page.
Steven L. Fasman is Senior Vice President, General Counsel and Corporate Secretary of the Company. Prior to that, he served as Executive Vice President-Law of MacAndrews & Forbes Holdings Inc., a privately held diversified holding company, from January 2012 to March 2014. Before that, Mr. Fasman held various positions at MacAndrews & Forbes since 1992 of increasing responsibility. From 2008 through March 2014, he also served as General Counsel and Chief Compliance Officer of M & F Worldwide Corp., a holding company with interests in financial products, customer calling centers, staffing operations, educational software and flavoring products. From 2008 to 2011, Mr. Fasman also served as a director of SIGA Technologies, Inc., a biodefense company. Mr. Fasman spent his early career at the law firm of Paul, Weiss, Rifkind, Wharton & Garrison, where he focused on domestic and international litigation and regulatory proceedings. Mr. Fasman holds a law degree from Yale University and an A.B. degree in mathematics from Princeton University. Mr. Fasman is a trustee of the Jewish Board of Family & Children’s Services in New York City.
As the Senior Vice President und General Counsel and Corporate Secretary of Catalent, the total compensation of Steven Fasman at Catalent is $1,688,530. There are 7 executives at Catalent getting paid more, with John Chiminski having the highest compensation of $8,514,990.
Steven Fasman is 57, he's been the Senior Vice President und General Counsel and Corporate Secretary of Catalent since 2014. There are 11 older and 15 younger executives at Catalent. The oldest executive at Catalent Inc. is Rolf Classon, 75, who is the Independent Director.
Steven's mailing address filed with the SEC is C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET, NJ, 08873.
Over the last 10 years, insiders at Catalent have traded over $2,686,980,380 worth of Catalent stock and bought 123,000 units worth $5,376,345 . The most active insiders traders include Management Associates V L.L..., Peter Zippelius und Frank A Damelio. On average, Catalent executives and independent directors trade stock every 17 days with the average trade being worth of $22,866,018. The most recent stock trade was executed by Ricky Hopson on 2 August 2024, trading 662 units of CTLT stock currently worth $39,429.
catalyst + talent. our name combines these ideas. from drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. with over 80 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance and provide superior, reliable manufacturing and packaging results. catalent develops. with our broad range of expert services we drive faster, more efficient development timelines to help you take more molecules to market and create more effective products. catalent delivers. as the world leader in drug delivery innovations, we have a proven record of enhancing bioavailability, solubility and permeability, improving ease and route of administration, and increasing patient compliance for better treatments. catalent supplies. globally positioned to serve all your manufacturing and commercial packaging needs, we p
Catalent executives and other stock owners filed with the SEC include: